BNP Paribas Financial Markets
IPSC icon

BNP Paribas Financial Markets’s Century Therapeutics IPSC Stock Holding History

BNP Paribas Financial Markets’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.21K Sell
1,418
-29
-2% -$61 ﹤0.01% 5372
2025
Q4 		$1.44K Sell
1,447
-31
-2% -$19 ﹤0.01% 5372
2025
Q3 		$736 Sell
1,478
-2,203
-60% -$1.19K ﹤0.01% 5268
2025
Q2 		$2.06K Sell
3,681
-601
-14% -$322 ﹤0.01% 5053
2025
Q1 		$2.04K Sell
4,282
-5,510
-56% -$4.14K ﹤0.01% 4982
2024
Q4 		$9.89K Buy
+9,792
New +$13.3K ﹤0.01% 4844

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

BNP Paribas Financial Markets's IPSC Position: Q1 2026 in Review

BNP Paribas Financial Markets reduced its Century Therapeutics (IPSC) stake by 2% in Q1 2026, selling an estimated $61 and leaving 1,418 shares worth $3.21K. The position accounts for ﹤0.01% of the portfolio, ranked #5372.

BNP Paribas Financial Markets first reported a position in IPSC in Q4 2024 and has held it in 6 quarters since. The position peaked at $9.89K in Q4 2024. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

  • BNP Paribas Financial Markets held 1,418 shares of Century Therapeutics worth $3.21K as of Q1 2026.
  • BNP Paribas Financial Markets sold 29 Century Therapeutics shares in Q1 2026, an estimated $61.
  • Century Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5372 holding.
  • BNP Paribas Financial Markets first reported a position in Century Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • BNP Paribas Financial Markets's Century Therapeutics position peaked at $9.89K in Q4 2024.
  • 72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.